Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.

O'Leary JG, Fontana RJ, Brown K, et al. Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study. Burton, Jr JR, Firpi-Morell R, Muir A, O'Brien C, Rabinovitz M, Reddy R, et al. Transpl Int. 2017;30(2):196 - 208.

Publication Type:

Journal Article

Authors:

O'Leary, Jacqueline G.; Robert J Fontana; Brown, Kimberly; et, al

Source:

Transpl Int, Volume 30, Issue 2, p.196 - 208 (2017)

Keywords:

infection-hepatitis B, C, liver clinical-other

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/27896858

Export Citation:
RIS Format
Top